About Us

Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Osteopore's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry. The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the Osteopore products provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.

Our Products

View all +


Osteoplug™ is a bioresorbable implant that is used for covering trephination burr holes in neurosurgery.


Osteomesh™ is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects.

Our Technology

Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use. Osteopore's proprietary technologies allow for the development of biostructures which are synthetic biologically active tissue engineered products for the restoration of the human skeleton. Osteopore's core technology, the 3D printed biomimetic micro architecture which facilitates the bone healing process, provides multiple opportunities for growth through developing surgical implants and for pursuing regulatory approval for its products to initiate revenue opportunities. 3D printed biomimetic micro architecture is used in all of Osteopore's products.


We are constantly looking for distributors who will market our products with the same passion as we do.

Know More
Contact Us

Conformance Standards

ISO 11137
ISO 11607
Quality systems
ISO 13485
(Certified in July 2007)

FDA QSR 820 MDD 93/42/EEC Annex II.3
ISO 14644-1
ISO 11137
ISO 10993

Regulatory Compliances

We strive to be a World Leader in Bioresorbable Scaffold Tissue Engineering by using Cutting-Edge Technology. We want to bring "A Message of Hope in Restoring Tissue to Normality" through the development of new scaffolds technologies and manufacturing medical devices which will repair and regenerate tissue that is both safe and effective while complying with all regulatory requirements for use.

View details